Ambev (NYSE:ABEV) Cut to Neutral at UBS Group

Ambev (NYSE:ABEV - Get Free Report) was downgraded by analysts at UBS Group from a "buy" rating to a "neutral" rating in a research note issued to investors on Tuesday, MarketBeat Ratings reports.

Other equities research analysts also recently issued research reports about the stock. Citigroup reissued a "neutral" rating on shares of Ambev in a research report on Wednesday, January 22nd. Bank of America lowered Ambev from a "buy" rating to a "neutral" rating in a research report on Friday, January 17th. StockNews.com started coverage on shares of Ambev in a research report on Tuesday, April 15th. They set a "buy" rating on the stock. Barclays dropped their price target on shares of Ambev from $2.50 to $2.00 and set an "equal weight" rating on the stock in a research report on Tuesday, January 21st. Finally, Morgan Stanley downgraded Ambev from an "equal weight" rating to an "underweight" rating in a research report on Monday, April 7th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $2.45.

Ambev Stock Down 0.4 %

ABEV opened at $2.39 on Tuesday. The company has a market cap of $37.65 billion, a PE ratio of 13.28, a price-to-earnings-growth ratio of 5.80 and a beta of 0.68. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.89 and a current ratio of 1.20. Ambev has a 1 year low of $1.76 and a 1 year high of $2.56. The firm has a 50 day moving average price of $2.20 and a 200 day moving average price of $2.11.

Ambev (NYSE:ABEV - Get Free Report) last posted its earnings results on Wednesday, February 26th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.06 by ($0.01). The business had revenue of $4.63 billion for the quarter, compared to analyst estimates of $22.42 billion. Ambev had a net margin of 17.02% and a return on equity of 16.12%. Sell-side analysts expect that Ambev will post 0.18 earnings per share for the current year.

Institutional Trading of Ambev

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ABEV. Insight Inv LLC bought a new stake in shares of Ambev in the 4th quarter worth approximately $25,000. GAMMA Investing LLC increased its holdings in Ambev by 468.4% in the 1st quarter. GAMMA Investing LLC now owns 10,998 shares of the company's stock valued at $26,000 after buying an additional 9,063 shares during the period. Generation Capital Management LLC acquired a new position in shares of Ambev in the 4th quarter valued at $28,000. Naviter Wealth LLC bought a new position in shares of Ambev during the 4th quarter worth about $29,000. Finally, Exchange Traded Concepts LLC acquired a new stake in shares of Ambev during the 4th quarter valued at about $30,000. Institutional investors and hedge funds own 8.13% of the company's stock.

Ambev Company Profile

Ambev SA, through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt and food, other alcoholic beverages, and non-alcoholic and non-carbonated products in Brazil, Central America and Caribbean, Latin America South, and Canada. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe, Hoegaarden, Balboa ICE, Balboa, Atlas Golden Light, Atlas, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Bud 66, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.